Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Magnetic Resonance in Chemistry : MRC|August 6, 2019
NMR characterization of rearranged staurosporine aglycone analogues from the marine sponge Damiria spTrong D Tran, Laura K Cartner, Heidi R Bokesch, et al.
Oncogene|April 6, 2004
The mismatch DNA repair heterodimer, hMSH2/6, regulates BLM helicaseQin Yang, Ran Zhang, Xin W Wang, et al.
Cancer Research|November 17, 2005
The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stressFrank Staib, Ana I Robles, Lyuba Varticovski, et al.
Hepatology (Baltimore, Md.)|July 2, 2020
MiR-125b Loss Activated HIF1α/pAKT Loop, Leading to Transarterial Chemoembolization Resistance in Hepatocellular CarcinomaXiyang Wei, Lei Zhao, Ruizhe Ren, et al.
Hepatology (Baltimore, Md.)|December 27, 2017
Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinomaChirag Nepal, Colm J O'Rourke, Douglas V N P Oliveira, et al.
Journal of the National Cancer Institute|August 10, 2007
Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifierMasahiro Seike, Nozomu Yanaihara, Elise D Bowman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 31, 2019
Urinary Metabolites Diagnostic and Prognostic of Intrahepatic CholangiocarcinomaMajda Haznadar, Christopher M Diehl, Amelia L Parker, et al.
Cancer Research|May 17, 2003
p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombinationSteven P Linke, Sagar Sengupta, Nissim Khabie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2020
Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract CancersDan Høgdall, Colm J O'Rourke, Christian Dehlendorff, et al.
JCI Insight|October 31, 2023
Diabetes-associated breast cancer is molecularly distinct and shows a DNA damage repair deficiencyGatikrushna Panigrahi, Julián Candia, Tiffany H Dorsey, et al.
Pageof 4